reason report
bottom line reiter op rate rais pt
compel transform agenda
acceler ep growth guidanc june i-day
impress detail underpin consum centric vision
reinvent local healthcar deliveri leverag retail commun
asset toward competit moat hard duplic
view financi pictur also encourag guidanc
re-affirmed guid conserv view in-lin
consensu low singl digit ep growth acceler
mid-singl low doubl digit ep growth
target increment oper incom across
synergi enterpris cost save transform off-set nt
headwind especi pbm lesser extent retail
busi balanc sheet expect delev current
debt ebitda
avail cash share repurchas need resum
build-out health fast becom realiti
plan underway histor capital-expenditure maintain
estim guidanc reaffirm ep lower
still consensu reflect meaning net loss pbm
busi acceler ep growth reflect new
guidanc pt repres price-to-earnings across averag
 ep
i-day paint compel vision consumer-centr
transform healthcar deliveri substanti detail
beyond financi agenda includ present ceo
rice presid caremark kevin hourican presid
transform consumer-centr reinvent local healthcar
deliveri offer strong competit moat pend success
execut model leverag commun asset multi-
mm oper incom expect transform
agenda medic cost save grow
 lt third come medic cost save aet insur
book vision retail health fast becom realiti
price-to-earnings averag
ep
net debt total capit
year price history/av daili volume mil
compani inform svb leerink llc research
revenu billion adjust ep
pleas refer page analyst certif import disclosur price chart disclosur specif
cover compani statement valuat risk avail
laser focu synergi cost effici toward sharehold
valu creation execut parallel transform
agenda ep growth guidanc strong acceler low
singl digit mid-singl digit low doubl digit
guidanc re-affirmed target increment
oper incom showcas strong focu valu creation
sharehold across aet synergi mm enterpris
 transform mm off-set nt
headwind pbm retail busi
ep growth low singl digit toward ep
exclud prior year develop in-lin consensu
conserv view retail busi health benefit
busi surpris posit pbm sell season disappoint
even amid weak consensu expect mm synergi across
combin cvs-aet organ mm enterpris
cost save expect off-set meaning pressur
net pbm contract loss competit price pressur busi
line return hipf headwind omnicar
perform guarante slow brand inflat expect
taper aet busi pois doubl digit membership
growth medicar advantag growth medicaid
healthcar benefit busi perform solidli profit
growth expect beyond guidanc solid growth
govern segment medicar advantag star
geograph expans medicaid expand commun
base primari care servic lower growth competit
challeng commerci busi expect deliv low singl digit
growth ancillari product penetr
pbm busi expect stabil declin
approv reduct specialti drug cost integr across
medic pharmaci expect drive improv
retail/ltc busi grow consensu expect
amid challeng backdrop best class asset
oper even today transform health
nation pharmaci grow industri
clinic servic network real estate/leas
optim underli industri growth
potenti shake-out groceri chain lag drug chain even
independ beauti contribut profit growth nt
enterpris cost save help off-set reimburs pressur
balanc sheet de-lever expect bring debt ratio
 aet deal debt
paid share repurchas dividend growth acceler
expect target leverag reach nt capit
alloc focus debt pay-down dividend
pay-out capital-expenditure risk base capit associ
valuat compel price-to-earnings averag
revis ep expect posit revis
price-to-earnings expans toward pt posit revis growth
medicar advantag balanc sheet de-lever closur polici
chang includ part rebat rule tx lawsuit possibl delay
hipf tax catalyst unlock valu
reiter op rate rais pt compel transform
agenda acceler ep growth guidanc june i-day impress
detail underpin consum centric vision reinvent local healthcar deliveri
leverag retail commun asset toward competit moat hard duplic
view
financi pictur also encourag guidanc re-affirmed guid
conserv view in-lin consensu low singl digit ep growth
acceler mid-singl low doubl digit ep growth target
 increment oper incom across aet synergi mm
enterpris optim transform mm off-set nt headwind
especi pbm lesser extent retail busi balanc sheet
expect delev current debt ebitda
 avail cash share repurchas need resum
build-out health fast becom realiti expect ground post
posit feedback three houston pilot plan underway
histor capital-expenditure
maintain estim guidanc reaffirm ep lower
still consensu reflect meaning net loss pbm busi continu
pressur pbm retail margin acceler ep growth reflect new
pt repres price-to-earnings across averag ep
posit revis growth medicar advantag balanc sheet de-lever closur
polici chang includ part rebat rule tx lawsuit possibl delay hipf tax
catalyst unlock valu
june i-day paint compel detail vision consumer-centr transform
healthcar deliveri substanti detail beyond financi agenda
includ present ceo larri merlo cfo eva boratto busi head across alan
manag present pack room june i-day nyc
transform consumer-centr reinvent local healthcar deliveri offer
commun asset multi-channel touch point across healthhub assist
telehealth seek becom neighborhood healthcar servic destin access
 popul live within mile store supplement
complement patient primari care physician cvss nurs practition
pharmacist pair health coach health concierg focu longitudin primari
care deliveri effect manag chronic diseas drive superior clinic outcom
particularli american senior
near ubiquit commun presenc transform one-stop-shop
multi-channel transform via product servic innov
commun touchpoint believ best posit solv client
biggest problem chronic high cost diseas larg oncolog kidney diseas rare
diseas requir specialti pharmaci diabet truli innov believ need
introduc new product market home hemodialysi machin new way
use appli knowledg healthhub concept importantli rapidli
effici scale innov vast commun footprint cvss develop home
hemodialysi exemplifi simplifi healthcar experi bring tool
home commun current await fda approv machin intend
use peopl caregiv home connect cloud
nephrologist cvss care team nurs abl connect monitor statu
differenti commun touchpoint design drive behavior chang costli
healthhub introduc store futur
first time laid ambiti plan roll new concept store
healthhub locat
healthhub management intend repurpos squar footag focu healthcar
servic mainli gear chronic care manag well care current pilot
locat houston market intend expand four metropolitan area
philadelphia/southern new jersey atlanta tampa healthhub ultim
goal store
importantli abl build store annual capital-expenditure budget
in-lin histor amount
intend transform consum health experi healthhub
deriv benefit reduct aet fulli insur book
remain payor agnost servic vast client base futur believ
abil enter share save contract non-aet plan sponsor
increas valu captur outsid aet book busi
marri physic digit touchpoint
cvss transform strategi marri physic digit touchpoint better
inform healthcar decision-mak navig supplement face-to-fac care
virtual care partnership partnership
ink august expand reach expect outreach digit
imposs staff bricks-and-mortar care provid necessari clinic program
leverag virtual physician in-stor specialti complex care distribut integr
virtual retail access employ health plan custom outsid aetna membership
marri physic digit touchpoint better inform healthcar decision-mak
select right market drive consum engag
select first market expand note look main criteria
densiti chronic condit within aet fulli insur book busi
quantum local healthcar servic avail abil easili transform
exist minuteclin healthhub roll healthhub util
caremark vast data asset determin largest densiti chronic condit
like biggest impact start look differ store archetyp
store gear toward millenni vs chronic diseas manag
open pilot healthhub year alreadi report impress consum
satisfact result overal net promot score vs chain store
transform deliveri drive enterpris growth
intend leverag commun asset becom one-stop-shop consum
healthcar need deepli ingrain consum routin all-in-al see
transform healthcar destin drive mm oper incom
medic cost save grow lt third come medic cost
save aet insur book
see four main lever pull drive growth via transform
aet medic save commun asset better manag chronic
care reduc wast spend readmiss via pharmacist-l intervent
improv prescript adher addit benefit design copay
aet direct member healthhub instead expens modal care
visit non-aet member healthhub payor-agnost aet member
non-memb alik abl util store servic
inform aet member benefit aet medic
cost reduct provid differ care mention
futur believ abil enter share save contract
addit prescript front-stor merchandis purchas mm
patient receiv care store like fill prescript store buy addit front-
store merchandis particularli merchandis focus health kevin hourican
presid pharmaci note interview hub store see high traffic
higher demand prescript medic servic sold higher margin item
averag
drive aet caremark membership growth eas obtain care
store like increas aet caremark valu proposit particularli low-
copay co-insur built benefit design usag healthhub
report major contribut factor one aet commerci win houston
year healthhub pilot program
laser focu synergi cost effici toward sharehold valu creation
execut parallel transform agenda ep growth guidanc strong
acceler low-singl digit mid-singl digit low-doubl digit
guidanc re-affirmed
ep guidanc strong acceler doubl digit
ep growth low-singl digit toward ep exclud prior year
develop in-lin consensu conserv view
expect mid-singl digit revenu growth high-singl digit oper incom growth
healthcar benefit low- mid-singl digit revenu growth low-singl digit oper
incom growth retail/ltc low- mid-singl digit revenu declin mid-singl digit
oper incom declin pbm
retail busi health benefit busi surpris posit pbm sell
season disappoint even amid weak consensu expect mm synergi across
combin cvs-aet organ mm enterpris cost save expect
off-set meaning pressur net pbm contract loss competit price pressur
busi line return hipf
headwind omnicar perform guarante slow brand inflat
expect taper aet busi pois doubl digit membership growth
medicar advantag growth medicaid
healthcar benefit expect mid-singl digit revenu growth high-singl digit
oper incom growth healthcar benefit
retail/ltc expect low- mid-singl digit revenu growth low-singl digit
pharmaci servic expect low- mid-singl digit revenu declin mid-singl digit
lower ep estim though view initi guidanc conserv svb leerink
con svblnewsvbl oldcon svblnewsvbl oldcon svblnewsvbl oldoper revenu incom bp chang leerink revenu estim guidanc svb leerink newsvb leerink oldguidancesvb leerink newsvb leerink oldsvb leerink newsvb leerink oldhealthcar benefit benefit adj adj adj adj repres midpoint corpor
longer term expect ep growth doubl digit
manag hold financi account success amid transform agenda
target increment oper incom showcas strong
focu valu creation sharehold increment revenu come aet
synergi mm enterpris optim transform mm
off-set nt headwind pbm retail busi
mm synergi larg busi integr
enterpris modern gener increment oper incom
transform gener increment mm oper incom grow
long term
target increment oper incom
healthcar benefit busi perform solidli profit growth expect
beyond guidanc solid growth govern segment medicar advantag
star geograph expans medicaid expand community-bas
medicar advantag fastest grow health benefit segment expect solid
doubl digit growth secular tailwind outsiz share gain
rate geograph expans drive continu growth
medicaid vast commun asset leverag complex popul
lower growth competit challeng commerci busi expect
deliv low-singl digit growth ancillari product penetr
competit growth commerci segment expect deliv -singl digit
pbm busi expect stabil declin contract loss amid
challeng competit backdrop biosimilar approv reduct specialti drug
cost integr across medic pharmaci expect drive improv
gener launch particularli complex singl sourc gener provid addit
biosimilar offer tailwind specialti rx segment
given nearli half specialti spend includ medic benefit take enterpris
approach limit drug growth
retail/ltc busi grow consensu expect amid challeng
backdrop best class asset oper even today transform
health nation
retail pharmaci report grow industri clinic servic
network real estate/leas optim underli industri
growth potenti shake-out groceri chain lag drug chain even
independ beauti contribut profit growth nt enterpris cost save
help margin preserv off-set reimburs pressur innov contract
transform store health community-bas care deliveri
model nation coverag drive strong barrier entri lead
way aet member steer store benefit design
incent model expect also payor agnost potenti share save
innov contract model
retail pharmaci grow industri larg clinic innov network
refocus front-stor sale higher margin health beauti item off-set digit
balanc sheet de-lever expect bring debt ratio low-
 aet deal debt paid share repurchas
dividend growth acceler expect target leverag reach nt capit
alloc focus debt pay-down dividend pay-out capital-expenditure
risk-bas capit associ insur premium growth
free gener lead leverag
capit deploy toward debt paydown near term
valuat compel view price-to-earnings averag revis
expect posit earn revis multipl expans toward pt
continu doubl digit growth medicar advantag mm member today balanc
sheet de-lever closur polici chang includ part rebat rule probabl
delay hipf tax favor rule tx lawsuit feder appel court
catalyst unlock valu
trade compel price-to-earnings
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans
pt contempl price-to-earnings averag ep
risk invest thesi valuat
legisl regulatori polici chang could either dis-intermedi
insur us benefit marketplac place unforeseen top-lin margin
headwind commerci medicar advantag medicaid dual elig book
not-for-profit health insur price irrat commerci health benefit
acceler employ exit sponsorship health benefit us
marketplac post implement afford act
advers select public exchang protect adequ given delay
true-up govern payment
acquisit asset without attract return capit investor
organiz and/or oper risk drive execut mis-step downsid risk
earn
primari valuat methodolog base absolut price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform dcf valuat
leverag forward forecast wacc termin growth rate inform
potenti multipl expans along sector compani specif catalyst expect
greater potenti multipl expans dcf valuat point significantli upsid
peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans
price target base price-to-earnings averag ep
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti econom downturn
provid re-up intens servic deliveri cobra acceler uptak
member util care advanc layoff pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz econom downturn
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus
longer term state-bas insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress potenti downsid membership
polit shock lead singl payer
compani specif risk signific declin equiti market could result increas fund
compani pension oblig polit legal oper regulatori econom
risk foreign oper
integr regulatori risk across merg ci esrx
pt contempl price-to-earnings averag ep
risk valuat includ
start-up cost underwrit issu associ new busi on-board
particularli challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state
legisl regulatori judici polici chang medicaid entitl program
state feder suprem court level also risk consid
pt contempl price-to-earnings averag ep
underwrit risk aet asset trade peak margin commerci fulli
insur though medacorp commerci broker price survey give us confid
price environ remain appropri hard offer flat even potenti
modestli expand underwrit margin risk potenti futur margin compress
aet health insur even meaning given associ neg impact
debt ebitda load compani need focus debt
pay next month departur shawn guertin aet cfo
slate becom cfo make us less confid price postur
health insur book commenc new bulk compet
share gain commerci medicar advantag market
macroeconom risk risk macroeconom downturn higher
defens pbm sub sector given cyclic correl retail front store
sale employ data
regulatori risk convinc pbm add valu earn
low probabl threat potenti drug manufactur rebat elimin off-set
new busi model includ administr fee and/or perform guarante
expos pbm retail pharmaci busi compar
player pbm risk
execut integr risk face greater risk well given integr
pbm broader organ also transform agenda around
build retail front model amid risk leverag balanc sheet
e-commerce/amzn greater exposur eros sale on-line
channel well given exposur retail front store retail pharmaci e-
commerc though larg price retail multipl expect less like
pursu agenda becom pbm given associ integr clinic evid
base treatment guidelin integr provid network domin captiv pbm
model mega deal
remain posit reiter op rate month pt
contempl price-to-earnings averag ep
risk invest thesi valuat legisl regulatori
polici chang could either dis-intermedi health insur us benefit
marketplac place unforeseen top-lin margin headwind commerci medicar
advantag medicaid dual elig book busi not-for-profit health insur
price irrat commerci health benefit marketplac acceler employ exit
sponsorship health benefit us marketplac post implement
afford act advers select public exchang protect adequ
given delay true-up govern payment acquisit asset
without attract return capit investor organiz and/or oper risk
lead execut mis-step downsid risk earn acceler medic cost trend
util improv economi servic arena yet yield adequ
return capit
sotp valuat point per share expect premium toward much
potenti takeout price per share see like buyer light
synergi medicaid complet pbm across ingeniorx optum rx
optum rx seek specialti rx expect look region player shore
medicaid pois well build third-parti servic platform best
place well pay cash also like interest given medicaid focu strategi
bring pbm in-hous would like pay asset equiti rather cash
delev fide transact financi buyer also like suitabl strateg
buyer identifi
start-up cost underwrit issu associ new busi on-board
particularli challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state
legisl regulatori judici polici chang medicaid
scale issu result loss specialti rx pharmaci contract
acquisit offer adequ return capit
upsid takeout substanti premium key risk
carve-out behavior health servic current state contract
pt contempl multipl averag
risk highlight first spike util on-board new state contract
dual elig integr second state-bas insur exchang result advers
select reduc sustain earn power third state-bas contract rate increas
suffici cover medic trend off-set industri fee medicaid premium fourth risk re-
procur exist contract could creat substanti downsid risk volatil fifth
legisl judici risk manag medicaid entitl extrem case singl
payer model also possibl downsid
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
rate outperform price target contempl price-to-earnings
averag cash ep
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti double-dip recess
provid re-up intens servic deliveri cobra acceler uptak member util
care advanc lay-off pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz double-dip recess
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus substanti
long-term state base health insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress also potenti downsid membership
risk relat collect industri fee medicar medicaid premium
polit shock lead singl payer
compani specif risk downsid risk price target includ acquisit asset
arena yield adequ return capit
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free yield ratio also inform potenti multipl expans
except low ratio and/or high free yield point potenti greater
base rate wcg outperform pt contempl price-to-earnings
averag ep
downsid risk price target includ execut new state contract dual elig
award rate increas suffici cover medic trend state clawback tax off-set tax
reform tailwind potenti dial medicaid expans ky upsid risk price
target includ take-out larger player
compani report svb leerink estim
incom revenu pbm retail oper invest futur pharmaci ens incl pension oper net incom share growth revenu includ corpor
compani report svb leerink estim
aetaetna inc aet incom invest realiz capit gains/loss after-tax includ transaction-rel cost net medic ratioscommerci risk non-risk advantag advantag hmo hmo hmo risk non-risk advantag corpor
compani report svb leerink estim
-key busi pharmaci mm retail pharmaci margin margin servic pbm choic network pharmaci servic revenu oper margin per adjust claim revenu pbm revenu ebitda margin ebitda servic segment pbm net revenu mail pharmaci claim process mail pharmaci adj store sale increas ss ss front ss rx ss adjust rx gener dispens total parti pharmaci retail prescript adj retail rx corpor
